TNSN96148A1 - Methode pour la synthese d'un benzimidazole. - Google Patents

Methode pour la synthese d'un benzimidazole.

Info

Publication number
TNSN96148A1
TNSN96148A1 TNTNSN96148A TNSN96148A TNSN96148A1 TN SN96148 A1 TNSN96148 A1 TN SN96148A1 TN TNSN96148 A TNTNSN96148 A TN TNSN96148A TN SN96148 A TNSN96148 A TN SN96148A TN SN96148 A1 TNSN96148 A1 TN SN96148A1
Authority
TN
Tunisia
Prior art keywords
fact
reaction sequence
benzimidazole
synthesis
pyrmethyl
Prior art date
Application number
TNTNSN96148A
Other languages
English (en)
Inventor
Gustavsson Anders
Kallstrom Ake
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN96148A1 publication Critical patent/TNSN96148A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UN PROCEDE POUR LA FABRICATION D'OMEPRAZOLE A PARTIR D'ALCOOL DE PYRMETHYLE EN PASSANT PAR LE CHLORURE DE PYRMETHYLE ET LE PYRMETAZOLE CARACTERISE PAR LE FAIT QUE LA SEQUENCE ENTIERE DE REACTION EST EFFECTUEE SANS AUCUNE ISOLATION OU PURIFICATION DES INTERMEDIAIRES. CE PROCEDE EST EGALEMENT CARACTERISE PAR LE FAIT QUE LES REACTIONS SE FONT DANS UN SEUL SYSTEME A SOLVANT, COMMUN A L'ENSEMBLE DE LA SEQUENCE DE REACTION, CE SOLVANT ETANT INERTE FACE AUX REACTANTS FORMES AU COURS DU PROCEDE ET UTILISES DANS CELUI-CI. LE PROCEDE DE LA PRESENTE INVENTION PEUT EGALEMENT COMPRENDRE UNE ETAPE DE PURIFICATION SUPPLEMENTAIRE.
TNTNSN96148A 1995-12-15 1996-12-02 Methode pour la synthese d'un benzimidazole. TNSN96148A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9504503A SE521100C2 (sv) 1995-12-15 1995-12-15 Förfarande för framställning av en bensimidazolförening

Publications (1)

Publication Number Publication Date
TNSN96148A1 true TNSN96148A1 (fr) 2005-03-15

Family

ID=20400614

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96148A TNSN96148A1 (fr) 1995-12-15 1996-12-02 Methode pour la synthese d'un benzimidazole.

Country Status (39)

Country Link
US (1) US5958955A (fr)
EP (1) EP0868423B1 (fr)
JP (1) JP3523267B2 (fr)
KR (1) KR100433436B1 (fr)
CN (1) CN1113879C (fr)
AR (1) AR004834A1 (fr)
AT (1) ATE205201T1 (fr)
AU (1) AU704422B2 (fr)
CA (1) CA2238864C (fr)
CO (1) CO4750654A1 (fr)
CZ (1) CZ288661B6 (fr)
DE (2) DE868423T1 (fr)
DK (1) DK0868423T3 (fr)
DZ (1) DZ2137A1 (fr)
EE (1) EE03768B1 (fr)
EG (1) EG23859A (fr)
ES (1) ES2125210T3 (fr)
HR (1) HRP960581B1 (fr)
HU (1) HUP9900110A3 (fr)
IL (1) IL124856A (fr)
IS (1) IS1891B (fr)
MA (1) MA24026A1 (fr)
MX (1) MX9804603A (fr)
MY (1) MY115661A (fr)
NO (1) NO314306B1 (fr)
NZ (1) NZ324482A (fr)
PL (1) PL186132B1 (fr)
PT (1) PT868423E (fr)
RU (1) RU2166502C2 (fr)
SE (1) SE521100C2 (fr)
SI (1) SI0868423T1 (fr)
SK (1) SK282347B6 (fr)
TN (1) TNSN96148A1 (fr)
TR (1) TR199801070T2 (fr)
TW (1) TW460474B (fr)
UA (1) UA62921C2 (fr)
WO (1) WO1997022603A1 (fr)
YU (1) YU49420B (fr)
ZA (1) ZA9610067B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SK283805B6 (sk) 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
US6303787B1 (en) * 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
UA72748C2 (en) * 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
DE19951960C2 (de) * 1999-10-28 2002-06-27 Gruenenthal Gmbh Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
RU2247120C2 (ru) * 1999-10-28 2005-02-27 Грюненталь Гмбх Способ получения противоязвенных терапевтических средств
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8691995B2 (en) 2004-12-16 2014-04-08 Cipla Limited Process
CN100393712C (zh) * 2006-01-23 2008-06-11 中国科学院成都有机化学有限公司 苯并咪唑型质子泵抑止剂及其前体的改进制备和分离纯化方法
WO2007122686A1 (fr) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. Composes benzimidazole
CA2889878A1 (fr) * 2007-02-21 2008-08-28 Cipla Limited Procede pour la preparation de esomeprazole magnesium dihydrate
CN101492459B (zh) * 2008-01-25 2011-04-27 山东轩竹医药科技有限公司 含烷氧乙酰基二氢异噁唑并吡啶化合物
CN101497603B (zh) * 2008-01-30 2012-11-07 山东轩竹医药科技有限公司 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
CN103664885A (zh) * 2013-12-12 2014-03-26 武汉工程大学 苯并咪唑型质子泵抑制剂中间体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US461997A (en) * 1891-10-27 Sand-pump or other pipes
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
US4619997A (en) * 1984-09-06 1986-10-28 The Upjohn Company Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening

Also Published As

Publication number Publication date
EG23859A (en) 2007-11-18
DE868423T1 (de) 1999-06-02
NZ324482A (en) 2000-04-28
ATE205201T1 (de) 2001-09-15
UA62921C2 (en) 2004-01-15
CN1204332A (zh) 1999-01-06
YU64296A (sh) 1999-07-28
NO982624L (no) 1998-06-08
EP0868423B1 (fr) 2001-09-05
HRP960581A2 (en) 1998-02-28
DK0868423T3 (da) 2001-12-03
SK76898A3 (en) 1998-12-02
CZ288661B6 (cs) 2001-08-15
KR100433436B1 (ko) 2004-07-16
AR004834A1 (es) 1999-03-10
EE03768B1 (et) 2002-06-17
EP0868423A1 (fr) 1998-10-07
HK1010539A1 (en) 1999-06-25
WO1997022603A1 (fr) 1997-06-26
MX9804603A (es) 1998-10-31
MY115661A (en) 2003-08-30
CO4750654A1 (es) 1999-03-31
RU2166502C2 (ru) 2001-05-10
SE9504503L (sv) 1997-06-16
HUP9900110A3 (en) 2002-10-28
DE69615052T2 (de) 2002-06-27
SI0868423T1 (en) 2002-04-30
ZA9610067B (en) 1997-06-17
US5958955A (en) 1999-09-28
SE9504503D0 (sv) 1995-12-15
JP3523267B2 (ja) 2004-04-26
IS1891B (is) 2003-09-19
ES2125210T1 (es) 1999-03-01
NO982624D0 (no) 1998-06-08
PL327334A1 (en) 1998-12-07
ES2125210T3 (es) 2002-02-01
YU49420B (sh) 2006-01-16
HRP960581B1 (en) 2001-12-31
IL124856A (en) 2002-12-01
SE521100C2 (sv) 2003-09-30
IL124856A0 (en) 1999-01-26
DE69615052D1 (de) 2001-10-11
IS4750A (is) 1998-05-22
CN1113879C (zh) 2003-07-09
CA2238864A1 (fr) 1997-06-26
AU1155097A (en) 1997-07-14
DZ2137A1 (fr) 2002-10-23
HUP9900110A2 (hu) 2000-03-28
EE9800183A (et) 1998-12-15
KR20000064399A (ko) 2000-11-06
PT868423E (pt) 2002-02-28
AU704422B2 (en) 1999-04-22
CZ168598A3 (cs) 1998-09-16
MA24026A1 (fr) 1997-07-01
CA2238864C (fr) 2006-01-24
TR199801070T2 (xx) 1998-08-21
SK282347B6 (sk) 2002-01-07
JP2000502101A (ja) 2000-02-22
TW460474B (en) 2001-10-21
NO314306B1 (no) 2003-03-03
PL186132B1 (pl) 2003-10-31

Similar Documents

Publication Publication Date Title
Keating et al. Molecular diversity via a convertible isocyanide in the Ugi four-component condensation
Terent'ev et al. A new method for the synthesis of bishydroperoxides based on a reaction of ketals with hydrogen peroxide catalyzed by boron trifluoride complexes
DK0781166T3 (da) Membranseparationsproces
SE9504503D0 (sv) Method for the synthesis of a benzimidazole compound
CA2355816A1 (fr) Systeme et procede de sequencage d'acides nucleiques mono-moleculaires par synthese de polymerase
Kobayashi et al. Preparation of optically active 2-furylcarbinols by kinetic resolution using the Sharpless reagent
PT1538202E (pt) Produção de alga-galactosidase a humana
ATE258379T1 (de) Nukleinsäure, die für einen tumor abstossungsantigenvorläufer kodiert
Tanaka et al. Palladium-Catalyzed Carbonylative [2+ 2] Cycloaddition for the Stereoselective Synthesis of Either cis-or trans-3-Alkenyl. beta.-Lactams
CA2250890A1 (fr) Procede d'epuration biologique d'eaux usees
Hayakawa et al. Reduction of 1, 2-diketones with titanium tetraiodide: a simple approach to α-hydroxy ketones
Zampella et al. Concise synthesis of all stereoisomers of β-methoxytyrosine and determination of the absolute configuration of the residue in callipeltin A
Ojima et al. Asymmetric synthesis with chiral. beta.-lactams.. alpha.-Substituted aromatic. alpha.-amino acids and their derivatives through highly stereoselective alkylations
JP2000086550A (ja) α―置換環系の合成方法
CA2250801A1 (fr) Procede de separation d'un catalyseur par electrodialyse membranaire
Kirschning et al. The first polymer-assisted solution-phase synthesis of deoxyglycosides
Green Improved metalation of 2, 4, 6-tribromoanisole: synthesis of 2-methoxyresorcinol
FR2743070B1 (fr) Procede pour la synthese d'arylhydrazine par reduction d'un derive diazoique
Hansen et al. Stereoselective synthesis of four stereoisomers of β-methoxytyrosine, a component of callipeltin A
KR900009595A (ko) 2-클로로-5-클로로메틸피리딘의 제조방법
Dussault et al. Stereoselective dioxygenation of enoates
FR2605094B1 (fr) Dispositif d'aide a l'acquisition de cible par un operateur dans un systeme d'armes
Nowaczyk et al. Asymmetric thio-claisen rearrangement induced by an enantiopure alkylsulfinyl group. Unusual preference for a boat transition state in the acyclic series
Totani et al. Highly Stereoselective 1, 4-Conjugate Addition of Organocopper Reagents to Methyl α-d-Glucopyranoside Derivatives Tethering an Unsaturated Ester Moiety at C-4 or C-61
RO91100A (fr) Procede pour la recuperation du ligande phosphoreux d'aldehydes voporises